Patient identifier: (b)(6).This report is being filed on an international product, list number 06p06-55 that has a similar product distributed in the us, list number 06p06-60.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and inhouse testing of a retained kit of reagent lot 27522be00.Return testing was not completed as returns were not available.Ticket and trending review did not identify any trends for the likely cause list or lot number.Data and information provided by the customer were reviewed and support the complaint issue without indication of any additional issue.Device history record review did not identify any potential non-conformances, non-conformances, or deviations associated with the likely cause lot.Inhouse testing of a retained kit of the likely cause lot was performed.Specifications were met indicating the lot is performing as expected.Labeling was reviewed which adequately addresses the current issue.Based on the investigation, no systemic issue or deficiency with the alinity s anti-hbc reagent lot 27522be00 was identified.
|